CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) , a wearable medical robotics company, announced today that Micah Mitchell is joining the company as chief commercial officer (CCO), a newly created executive role. The addition of a CCO reflects Myomo’s transition from a controlled introduction of its proprietary MyoPro product line to expansion of its sales, marketing, and distribution activities to address the large unmet need of expanded mobility for individuals with arm and hand paralysis.
Mitchell will report to CEO Paul R. Gudonis and work with Davie Mendelsohn, Myomo’s vice president of sales and clinical services, to grow the company’s network of MyoPro Centers of Excellence, expand its field staff of business development and clinical professionals, and generate demand for its product line among patients, physicians and therapists.
Mitchell has extensive experience growing revenues for companies in the durable medical equipment industry, including companies that provide customized wheelchair and mobility solutions to those with paralysis due to spinal cord injuries and other neurological conditions. He has served in sales management and executive roles at Invacare, Alliance Seating and Mobility, and Apria Healthcare Group, where he expanded their field sales organizations, conducted direct-to-consumer marketing campaigns, and obtained reimbursement for their products to increase patient access to the technology.
“Now that we have embarked on scaling up our commercial operations to bring the MyoPro to the many people who could benefit from this life-changing product line, we are pleased to have an executive of Micah’s stature join our senior management team,” Gudonis said. “He has a track record of growing revenues, and he will collaborate with our chief marketing officer, chief medical officer and operations management to develop and implement programs that provide the MyoPro to a greater number of patients through our clinical channel partners.”
Mitchell earned a BS in Economics from Baylor University and an MBA from the McCombs School of Business at The University of Texas at Austin.
About Myomo
Myomo, Inc. is a wearable medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.
